| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2023 | The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Pierson, Maud; Lenaerts, Melissa; MEBIS, Jeroen | Journal Contribution | A1 |
| 2 | 2023 | Evaluation of a novel skin care product for the management of chemotherapy– related dermatologic toxicities: A quasi-experimental study | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Tuts, Laura; Lenaerts, Melissa; Wessels, Tim; Requilé, Annelies; Luyten, Daisy; Verheezen, Jolanda; Joosens, Eric; MEBIS, Jeroen | Journal Contribution | A1 |
| 3 | 2023 | Photobiomodulation in the management of chemotherapy-induced peripheral neuropathy: a randomized, controlled trial | CLAES, Marithe; LODEWIJCKX, Joy; Hermans, S.; Peeters, P.; MEBIS, Jeroen; ROBIJNS, Jolien | Journal Contribution | M |
| 4 | 2023 | A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial | ROBIJNS, Jolien; Van Bever, Leen; Hermans, Sanne; CLAES, Marithe; LODEWIJCKX, Joy; Lenaerts, Melissa; Tuts, Laura; Vandaele, Eline; Vinken, Evelien; Noé, Leen; Verboven, Katleen; MAES, Annelies; Van de Velde, Anne-Sophie; BULENS, Paul; Bulens, Philippe; Van den Bergh, Laura; MEBIS, Jeroen | Journal Contribution | A1 |
| 5 | 2022 | Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; MEBIS, Jeroen | Journal Contribution | M |
| 6 | 2022 | Photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Hermans, S.; MEBIS, Jeroen | Journal Contribution | M |
| 7 | 2022 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMIS- HEAD trial)" by He et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes , Stefan; Van Bever, Leen; Pannekoeke , Luc; Censabella, Sandrine; Busse, Lore; COLSON, Dora; Kaminski, Iris; Broux, Victoria; Puts , Sofie; Vanmechelen, Sofie; Timmermans, An; Noe, Leen; BULENS, Paul; Govers, Mieke; Maes, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 8 | 2022 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole‐breast irradiation (LABRA trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Puts, Sofie; Timmermans, An; Noe, Leen; Vanmechelen, Sofie; Govers, Mieke; Van de Werf, Evelyn; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen; Claes, Stefan; Pannekoeke, Luc | Journal Contribution | A1 |
| 9 | 2022 | Photobiomodulation therapy for the prevention and management of chemotherapy-induced peripheral neuropathy and chemotherapy-induced alopecia | LODEWIJCKX, Joy | Theses and Dissertations | T1 |
| 10 | 2022 | Photobiomodulation Therapy in Management of Cancer Therapy-Induced Side Effects: WALT Position Paper 2022 | ROBIJNS, Jolien; LODEWIJCKX, Joy; Arany, Praveen; Barasch, Andrei; Jan, Bjordal; Bossi, Paolo; Chilles, Anne; Corby, Patricia; Epstein, Joel; Elad, Sharon; Fekrazad, Reza; Fregnani, Eduardo; Genot, Marie-Thérèse; Ibarra, Ana; Hamblin, Michael; Heiskanen, Vladimir; Hu, Ken; Klastersky, Jean; Lalla, Raj; Latifian, Sofia; Maiya, Arun; MEBIS, Jeroen; Migliorati, Cesar; Milstein, Dan; Murhpy, Barbara; Raber-Durlacher, Judith; Roseboom, Hendrik; Sonis, Stephen; Treister, Nathaniel; Zadik, Yehuda; Bensadoun, René-Jean | Journal Contribution | A1 |
| 11 | 2022 | The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Evens, Stijn; Swinnen, Laura; Lenders, Hilde; Bortels, Sandra; Nassen, Wendy; Hilkens, Ruth; Raymakers, Liesbeth; Snoekx, Sylvana; Hermans, Sylvia; MEBIS, Jeroen | Journal Contribution | A1 |
| 12 | 2022 | A long‐term follow‐up of early breast cancer patients treated with photobiomodulation during conventional fractionation radiotherapy in the prevention of acute radiation dermatitis | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Lenaerts, Melissa; Van Bever, Leen; Claes, Stefan; Pannekoeke, Luc; Verboven, Katleen; Noé, Leen; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 13 | 2021 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; Timmermans, An; Noé, Leen; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 14 | 2021 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 15 | 2021 | Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Govers, Mieke; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; BULENS, Paul; Vanmechelen, Sofie; MAES, Annelies; MEBIS, Jeroen; Claes, Stefan | Journal Contribution | A1 |
| 16 | 2021 | The safe use of photobiomodulation therapy in an oncologic setting | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | M |
| 17 | 2021 | The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: Preliminary results of a randomized, placebo-controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; Hermans, S; MEBIS, Jeroen | Journal Contribution | M |
| 18 | 2021 | A digital automated health monitoring system for oncology patients during the COVID-19 pandemic: Practical issues and lessons for the future | ROBIJNS, Jolien; LODEWIJCKX, Joy; WIJNEN, Katrien; Snoekx, Sylvana; Hilkens, Ruth; Bortels, Sandra; Lenders, Hilde; Nassen, Wendy; Dewaele, Elien; Luyten, D.; Joosens, Eric; Requilé, Annelies; Verheezen, Yolanda; Wessels, Tim; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 19 | 2021 | Photobiomodulation therapy can prevent the development of severe acute radiodermatitis in head and neck cancer patients: A multicentric, randomized controlled trial | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | M |
| 20 | 2020 | Photobiomodulation Therapy for the Management of Chemotherapy-Induced Peripheral Neuropathy: An Overview | LODEWIJCKX, Joy; ROBIJNS, Jolien; Bensadoun, René-Jean; MEBIS, Jeroen | Journal Contribution | A1 |